{
    "2020-03-04": [
        [
            {
                "time": "",
                "original_text": "在带量采购冲击下，国产创新药及CRO企业更受关注",
                "features": {
                    "keywords": [
                        "带量采购",
                        "国产创新药",
                        "CRO企业"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "一周内，新华医疗等多家药企高管发生人事变动 董监高成员变化",
                "features": {
                    "keywords": [
                        "新华医疗",
                        "药企",
                        "高管变动",
                        "董监高"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}